RS7258249 Unknown gene

Other Chr 19:8206837
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:Sphingolipid Concentrations]"
GWAS Studies (16)
Trait Risk Allele OR / Beta P-value Study
Sphingomyelin (d38:1) levels A OR: 0.22 3E-37 PubMed
Sphingolipid levels β: 0 1E-34 PubMed
Monohexosylceramide (d16:1/20:0) levels A OR: 0.25 6E-30 PubMed
Sphingolipid levels G β: 0 2E-27 PubMed
Sphingomyelin (d38:1) levels A OR: 0.23 2E-24 PubMed
Monohexosylceramide (d16:1/22:0) levels A OR: 0.23 4E-24 PubMed
Sphingomyelin (d18:1/19:0, d19:1/18:0) levels A OR: 0.19 3E-23 PubMed
Trihexosylcermide (d18:1/20:0) levels A OR: 0.21 2E-21 PubMed
Trihexosylcermide (d18:1/20:0) levels A OR: 0.19 2E-17 PubMed
Serum metabolite levels G OR: 0.17 3E-11 PubMed
Sphingomyelin (d18:1/20:1, d18:2/20:0) levels in elite athletes OR: 0.4 7E-11 PubMed
Sphingomyelin(38:1)_[M+H]1+ levels A β: 0.071 2E-10 PubMed
Red cell distribution width A β: 0.014 3E-10 PubMed
Palmitoyl dihydrosphingomyelin (d18:0/16:0) levels A β: 0.065 3E-10 PubMed
Sphingomyelin (d18:1/18:1, d18:2/18:0) levels in elite athletes OR: 0.32 3E-7 PubMed
Stearoyl sphingomyelin (d18:1/18:0) levels in elite athletes OR: 0.31 3E-7 PubMed
Ask Dr. Hemsworth about this variant